Astec Lifesciences Ltd. | Income Statement
Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
2,063
2,660
2,299
2,944
3,613
Cost of Goods Sold (COGS) incl. D&A
1,739
2,106
1,899
2,335
2,959
Gross Income
324
554
401
609
654
SG&A Expense
101
136
155
125
157
Unusual Expense
6
105
31
106
40
Non Operating Income/Expense
16
3
17
15
132
Interest Expense
92
128
128
122
107
Pretax Income
111
190
124
287
557
Income Tax
25
42
74
96
207
Consolidated Net Income
87
148
51
192
350
Net Income
87
148
50
191
349
Net Income After Extraordinaries
87
84
50
191
349
Net Income Available to Common
87
148
50
191
349
EPS (Basic)
4.68
7.59
2.55
9.81
17.88
Basic Shares Outstanding
19
19
19
19
20
EPS (Diluted)
4.68
10.88
2.54
9.78
17.84
Diluted Shares Outstanding
19
19
20
20
20
EBITDA
370
545
345
628
630
Other Operating Expense
-
1
5
8
14
Non-Operating Interest Income
3
8
26
10
9
Minority Interest Expense
-
-
1
1
1
About Astec Lifesciences
View Profile
